RecallWatchUSA

Home / Recalls

Consumer Product Recalls

127,244 recalls from the U.S. Consumer Product Safety Commission, newest first.

December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Extension Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Spa
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Extension Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Spa
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Extension Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Spa
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Caresite utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space La
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Caresite utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space La
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Caresite utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space La
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls CARESAFE utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space La
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Burette Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Burette Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Blood Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's In
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Blood Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's In
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Blood Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's In
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Blood Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's In
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Blood Administration Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's In
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls B.BRAUN utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Lar
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls Anesthesia IV Set utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls ADDitIV utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Lar
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls ADDitIV utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Lar
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
B Braun Medical Inc recalls ADDitIV utilized in gravity IV administration sets and pump administration sets utilized with BBMI's Infusomat Space Lar
Hazard: Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
December 3, 2025Medical DevicesFDA
BioFire Diagnostics, LLC recalls BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)
Hazard: Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.
December 3, 2025Medical DevicesFDA
Stryker Corporation recalls NICO BrainPath; Product Number/Product Name NN-8024 BrainPath Shephard's Hook - Greenberg; NN-8025 BrainPath Shep
Hazard: Tape used to secure components within packaging contains latex, despite products being labeled as latex-free. Latex could potentially cause an allergic reaction.
December 3, 2025Medical DevicesFDA
Stryker Corporation recalls NICO Myriad Illumination Pack Product No. NN-1000 11g Illumination Sleeve/Fiber; Product No. NN-1001 13g Illuminat
Hazard: Tape used to secure components within packaging contains latex, despite products being labeled as latex-free. Latex could potentially cause an allergic reaction.